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Aim: Advanced age is associated with vascular endothelial dysfunction, characterized 
by reductions in endothelium-dependent vasodilation of conduit and resistance 
arteries, in part from decreased nitric oxide (NO) bioavailability. Although vascular 
smooth muscle function (SMF), assessed by responsiveness to an exogenous NO 
donor, is typically reported to be intact, many of these studies are limited by small 
sample size. Therefore, the purpose of this meta-analysis is to systematically review 
and determine whether vascular SMF is different between older versus young healthy 
subjects. 
Design: We conducted a systematic search of MEDLINE, Cochrane and Scopus, since 
their inceptions until January 2014 for articles evaluating SMF in the brachial artery 
and/or resistance arteries (BASMF and RASMF, respectively), as assessed by the 
endothelium-independent vasodilator response to exogenous NO donors in older 
(≥60 years) and young (<30 years) groups of healthy subjects. Meta-analyses were 
performed to compare the mean difference (MD) in BASMF and the standardized 
mean difference (SMD) in RASMF between older and young groups. Subgroup analyses 
were performed to identify sources of heterogeneity. 
Results: Fifteen studies assessing BASMF and 20 studies assessing RASMF were 
included, comprising 550 older and 516 young healthy subjects. After data pooling, 
BASMF and RASMF were lower in older compared with young groups (MD=-1.89 %, 
P=0.04; SMD=-0.46, P=0.0008, respectively). Significant heterogeneity was observed in 
the BASMF (I2=74 %; P<0.00001) and RASMF (I2=57 %; P=0.0008) meta-analyses. 
Subgroup analyses revealed that studies with (predominantly) males showed similar 
SMF responses between older and young groups. 
Conclusions: Based on current published studies, vascular SMF is reduced in conduit 
and resistance arteries of otherwise healthy older subjects, particularly in women.  
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INTRODUCTION  1 
Older age is a primary risk factor for the development of cardiovascular diseases [1, 2]. 2 
The influence of advanced age on increased cardiovascular risk is, at least partly, 3 
mediated through its effects on the arterial vasculature [1].  In this regard, ageing is 4 
associated with vascular endothelial dysfunction in humans, characterized by reduced 5 
endothelium-dependent vasodilator function in conduit [3-13] and resistance [6, 9, 14-6 
24] arteries.  Alterations in the nitric oxide (NO) signaling pathway and/or decreased 7 
NO bioavailability have been proposed to contribute to the age-related decrease in 8 
endothelium-dependent vasodilator function [25, 26].  9 
 10 
The ability of vessels to dilate is dependent on the function of the endothelium, but is 11 
also subordinated to vascular smooth muscle (vasodilator) function (SMF). Smooth 12 
muscle responsiveness represents the final, and frequently underappreciated, step of 13 
endothelium-dependent vasodilation. However, relatively little is known about the 14 
impact of advanced age on SMF. Some reports from animal studies indicate that 15 
advanced age is associated with reduced vascular SMF [27-29]; nonetheless, this finding 16 
is not universal [25]. In humans, studies assessing vascular SMF in healthy older and 17 
young subjects have reported variable results, possibly as a result of small sample sizes 18 
[3-6, 8-10, 12, 14-24, 30-43].  19 
 20 
Therefore, the primary aim of this study was to perform a systematic review and meta-21 
analyses of available studies comparing vascular SMF in older and young healthy 22 
subjects.  We hypothesized that SMF would be reduced in conduit and resistance 23 
arteries of older compared with young healthy adults. We selected studies that 24 
assessed SMF, determined by the endothelium-independent vasodilator response to 25 
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exogenous NO donors, in the brachial artery (BASMF) and in resistance arteries 26 
(RASMF) of healthy young and healthy older subjects. 27 
 28 
METHODS 29 
The review is reported according to the Meta-analysis Of Observational Studies in 30 
Epidemiology (MOOSE) Group guidelines [44].  31 
 32 
Data sources and searches 33 
Our systematic search included MEDLINE, Cochrane and Scopus, since their 34 
inceptions until January 2014. We used combinations of the subject headings “older”, 35 
“vascular smooth muscle”, “endothelium independent”, “nitroglycerin”, “sodium 36 
nitroprusside”, “vascular function”, “vasodilation” and “vascular reactivity”; the search 37 
strategy for MEDLINE is shown in Supplemental Figure S1. We also performed hand 38 
searching in reference citations of articles included in meta-analysis and related 39 
citations in MEDLINE.  40 
 41 
Study selection  42 
To be included in the analysis, an observational report had to assess BASMF and/or 43 
RASMF in an older group (mean age ≥60 years) and a young group (mean age <30 44 
years) of healthy subjects. In the event of multiple publications pertaining to the same 45 
research, the first published or most comprehensive study was included. Inclusion of 46 
studies was not limited by publication status or language.  47 
 48 
Data extraction and quality assessment 49 
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The following variables were extracted into a pre-formatted spreadsheet: authors, year 50 
of publication, characteristics of study participants (n, gender, age, height, weight, body 51 
mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), 52 
physical activity, maximal oxygen consumption (VO2max), morbidities, risk factors to 53 
health, medication) and vascular variables (vascular region, vasodilation parameter, 54 
baseline vascular tone, NO donor, dosage, time of analysis after NO donor 55 
administration, wall-tracking system, BASMF, RASMF, endothelial function). A 56 
systematic appraisal of quality for observational research (SAQOR) [45] previously 57 
applied in meta-analysis of observational studies evaluating arterial function [46] was 58 
performed to provide assessment of study quality. The SAQOR was adjusted to assess 59 
1) the older sample group, 2) the young sample group, 3) quality of vascular SMF 60 
measurement, 4) confounding variables and 5) data. Overall, the SAQOR was scored 61 
out of 16, quality deemed better with a greater score (Table S1 and S2).  62 
 63 
Data synthesis and analysis 64 
The meta-analyses and subgroup analyses were performed using Review Manager 65 
software (RevMan 5.2, Cochrane Collaboration, Oxford, UK). The primary outcomes 66 
were the mean difference (MD) in BASMF and the standardized mean difference (SMD) 67 
in RASMF between older and young groups. SMD summary statistic allowed us to 68 
standardize RASMF values expressed in different units into a uniform scale to complete 69 
this meta-analysis. Each MD and SMD was weighted according to the inverse variance 70 
method [47] and they were pooled with a random-effects model [48]. SMD of 0.2, 0.5, 71 
and 0.8 represents small, medium, and large effect sizes, respectively [49]. 72 
Heterogeneity between studies was assessed using the chi-squared test for 73 
heterogeneity and I2 statistics. Potential moderating factors were evaluated by 74 
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subgroup analysis comparing studies grouped by dichotomous or continuous variables 75 
potentially influencing vascular SMF. Median values of continuous variables were used 76 
as cut-off values for grouping studies. Publication bias was evaluated by estimating the 77 
asymmetry of the Begg and Mazumdar’s funnel plot [50]. A P value of less than 0.05 78 
was considered statistically significant. 79 
 80 
RESULTS 81 
Study selection and characteristics  82 
The flow diagram of the process of study selection is shown in Figure 1, which resulted 83 
in the inclusion of 33 articles. Thirteen of these articles assessed BASMF, 19 assessed 84 
RASMF and 1 assessed both BASMF and RASMF. One of the articles assessing BASMF 85 
presented two groups of older subjects, each of which had been independently 86 
compared with a location-matched young group [43]. Therefore, these data were 87 
evaluated as two individual studies. Table 1 shows the main clinical characteristics of 88 
the 15 BASMF studies and 20 RASMF studies, comprising a total of 550 subjects in the 89 
older group and 516 subjects in the young group. Older and young groups were 90 
gender-matched in all studies (omitting 1 study in which gender-related data was not 91 
available [22]). All subjects were free from co-morbidities and risk factors according to 92 
cut-off values, non-smokers (except for 1 study allowing < 5 cigarettes per day [23]) 93 
and not taking medications (other than oral contraceptives reported in 1 study [31]). 94 
The quality of the studies was moderate-to-high according to a previously validated 95 
scale [45, 51]. The mean score was 13.9±1.2 for studies assessing BASMF and 11.8±1.2 96 
for studies assessing RVSMF, out of a possible 16 points (Table S1 and S2). As for the 97 
evaluation of potential bias, the Begg and Mazumdar’s funnel plot for the MD in BASMF 98 
was moderately asymmetric, suggesting the presence of publication bias and/or other 99 
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biases (Figure S2). The Begg and Mazumdar’s funnel plot for the SMD in RVSMF was 100 
relatively symmetrical (Figure S3).  101 
 102 
Brachial artery smooth muscle function (BASMF) 103 
All studies assessing BASMF evaluated the vasodilator response to 0.4 mg of 104 
nitroglycerin by means of high-resolution ultrasound (Table 2). Resting brachial 105 
diameter ranged from 3.0 to 4.4 mm, with older groups commonly presenting a larger 106 
resting brachial diameter than young groups. After data pooling, the meta-analysis 107 
revealed that BASMF was lower in older compared with young groups (15 studies, 108 
MD=-1.89%; P=0.04) (Figure 2). Significant heterogeneity was detected (I2=74%; 109 
P<0.00001). In subgroup analyses, studies above the median in presence of females in 110 
the study group showed lower BASMF in older compared with young groups (8 111 
studies, MD=-3.38%; P=0.01).  In contrast, studies below the median in presence of 112 
females had similar BASMF in older and young groups (7 studies, MD=0.19%; P=0.80).  113 
Both sex subgroups were significantly different when compared with each other 114 
(P=0.02) (Table S3). In addition, lower brachial artery endothelial function in older 115 
compared with young groups was related to lower BASMF (P=0.03, Table S3). No 116 
other potential moderating factor (n, age, height, weight, BMI, SBP, DBP, VO2max, 117 
vascular assessment, methodological quality, year of publication) significantly influenced 118 
the MD in BASMF between older and young groups in subgroup analyses (Table S3). 119 
 120 
Resistance artery smooth muscle function (RASMF) 121 
RASMF was determined by evaluating the absolute peak [6, 14, 15, 18, 23, 24, 30-33, 122 
35], percent increase from baseline [8, 9, 16, 17, 19-21, 34] or slope [22] in 123 
vasodilation in response to sodium nitroprusside (Table 3). After data pooling, the 124 
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RASMF was lower in older compared with young groups (20 studies, SMD=-0.46; 125 
P=0.0008) (Figure 3). Significant heterogeneity was detected (I2=57%; P=0.0008). In 126 
subgroup analyses, studies above the median in presence of females showed lower 127 
RASMF in older compared with young groups (10 studies, SMD=-0.77; P=0.001). In 128 
contrast, studies below the median in presence of females presented similar RASMF in 129 
older and young groups (9 studies, SMD=-0.17; P=0.20). Both sex subgroups were 130 
significantly different when compared with each other (P=0.02) (Table S3). No other 131 
potential moderating factor (n, age, height, weight, BMI, SBP, DBP, VO2max, vascular 132 
assessment, methodological quality, year of publication) significantly influenced the 133 
SMD in RASMF between older and young groups (Table S3). 134 
 135 
DISCUSSION 136 
In this systematic review and meta-analysis, we pooled and analyzed data from 33 137 
articles comparing vascular SMF, determined by the vasodilator response to exogenous 138 
NO donors, in 550 older and 516 young healthy subjects. The main finding of this 139 
meta-analysis is that vascular SMF is significantly lower in older compared to young 140 
individuals, a finding that is similarly present in conduit and resistance arteries (Figure 2 141 
and 3). In subgroup analyses, we found that sex altered the impact of age on vascular 142 
SMF.  More specifically, studies including females only or a higher ratio of females to 143 
males displayed a significant and marked impact of age on conduit and resistance artery 144 
SMF, whilst studies involving males only or a lower ratio of females to males reported 145 
no effect of age on SMF (Table S3).  146 
 147 
The impact of age on vascular SMF had not been explored in detail in most previous 148 
individual studies (Table 2 and 3), possibly because of low statistical power and 149 
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presence of confounding factors inherent in cross-sectional comparisons. Results from 150 
this meta-analysis indicate that, in addition to endothelial dysfunction, older age is 151 
associated with smooth muscle dysfunction in conduit and resistance arteries, as 152 
represented by reduced smooth muscle sensitivity to a NO donor. Consistent with 153 
this finding, studies performed in older rats demonstrated reduced vasodilator 154 
response to NO [27-29] and decreased vascular smooth muscle expression of soluble 155 
guanylyl cyclase (sGC) [27, 52] (i.e., the principal intracellular receptor of NO and 156 
mediates vasodilation via formation of cyclic guanosine monophosphate (cGMP) [53]). 157 
In humans, decreased expression and activity of sGC in brain tissue have been related 158 
to advanced age and Alzheimer’s disease, respectively, although no specific vascular 159 
measures were provided [54, 55]. Whether an age-related reduction in expression and 160 
activity of sGC in vascular smooth muscle contributes to a blunted vascular 161 
responsiveness to NO needs further investigation.  162 
 163 
A consistent finding from previous studies is that brachial artery flow-mediated 164 
dilation, as well as resistance artery responses to acetylcholine, are impaired in older 165 
healthy humans. As most of these previous studies found no difference in the 166 
endothelium-independent vasodilation to exogenous NO donors, the general 167 
consensus was that the lower flow-mediated dilation and resistance artery responses 168 
to acetylcholine supported the presence of a dysfunctional endothelium.  Our results, 169 
however, suggest the presence of a small-to-moderate but significant age-related 170 
impairment in SMF that is present across the vascular tree. Moreover, our finding also 171 
suggests that a portion of the impaired NO-dependent responses in conduit and 172 
resistance arteries in older healthy subjects may be in part due to reduced smooth 173 
muscle sensitivity to NO. This important observation should be taken into 174 
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consideration when interpreting the lower NO-dependent responses in healthy older 175 
humans.  176 
 177 
Another important finding of this meta-analysis was the influence of sex on the 178 
difference in vascular SMF between young and older humans. Studies that involved 179 
(predominantly) males, which is a common observation in studies in the field of 180 
cardiovascular physiology, found similar BASMF and RASMF between older and young 181 
groups. However, studies with females only or studies with a relatively high ratio of 182 
females to males reported a significantly lower BASMF and RASMF in the older group 183 
compared with the young group. One potential explanation for this finding may be 184 
related to menopausal status in women. Indeed, reduced vasodilation to exogenous 185 
NO donors has been reported in conduit and resistance arteries of healthy older 186 
women but not in those on hormonal replacement therapy. This suggests that 187 
hormone replacement therapy in postmenopausal women may preserve the sensitivity 188 
of vascular smooth muscle to NO [56-58]. In this regard, it is important to emphasize 189 
that none of the studies included in our meta-analyses involved women on hormonal 190 
therapy. Consequently, based on the assumption that the majority of older women 191 
were post-menopausal, the lower vascular SMF in older groups could be a result of the 192 
loss of vascular protection from circulating estrogens associated with post-menopause. 193 
Nevertheless, removal of estrogen with ovariectomy in rodents does not appear to 194 
alter vasodilator responses to sodium nitroprusside [59, 60], suggesting that loss of 195 
estrogen after menopause may not be the sole factor contributing to reduced vascular 196 
SMF in older women. Alternatively, estrogen-independent alterations in the NO 197 
signaling pathway could underlie the altered vascular SMF in older women in view of 198 
the decreased NO-stimulated vascular cGMP formation in middle-aged and older 199 
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women (with no report of menopause) compared with men [61]. Whilst speculative, 200 
the sex-related reduced vascular sensitivity to NO might partly explain why women 201 
remain more symptomatic and present lower cardiovascular status compared with 202 
men after long-term nitrate therapy for heart failure [62]. 203 
 204 
A potential explanation for a lower NO-mediated dilation of the brachial artery in 205 
older subjects may relate to the larger baseline diameter. As demonstrated in several 206 
previous studies, the brachial artery dilator response to ischemia or glyceryl trinitrate 207 
is inversely related to the baseline diameter [63-67]. Nonetheless, in the present study, 208 
the difference in baseline brachial diameter between older and young groups did not 209 
modify the MD in BASMF according to subgroup analysis (Table S3). Moreover, the 210 
magnitude of the difference in baseline brachial diameter between older men and 211 
young men (4 studies) was not different than the difference between older women and 212 
young women (3 studies) (P=0.24). Furthermore, the impact of sex on BASMF is not 213 
explained by artery diameter [68]. Taken together, we believe differences in brachial 214 
artery diameter between older and young groups do not entirely explain the age-215 
related decline in BASMF observed in the present meta-analysis.  216 
 217 
As for the prognostic value of vascular SMF, adverse cardiovascular events were 218 
associated with reduced smooth muscle sensitivity to NO in high-risk populations 219 
when assessed in conduit [69] and resistance arteries [70] by means of ultrasound and 220 
plethysmography, respectively. It should be noted that blood flow responses in the 221 
microcirculation assessed via plethysmography and laser Doppler techniques —such as 222 
those used in the studies included in the RASMF meta-analysis— may be, to a certain 223 
degree, dependent on microvascular structure, which in turn is strongly associated 224 
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with cardiovascular events [71]. Conversely, NO-dependent responses determined by 225 
micromyography did not predict cardiovascular events in high-risk patients, suggesting 226 
that resistance artery function per se has low clinical relevance [72]. Similarly, it cannot 227 
be discarded that the age-related reduction in RASMF is an observation dependent on 228 
differences in microvascular structure. Further research is warranted to determine the 229 
extent to which vascular structural changes with ageing influence the non-invasive 230 
estimates of smooth muscle responsiveness to NO and their clinical significance.   231 
 232 
There are some limitations in this meta-analysis. First, cross-sectional comparisons may 233 
be misleading when addressing the question of the impact of advanced age [73]. 234 
Second, we were unable to accurately determine the level of physical activity or fitness 235 
in the included studies. Since physical activity or exercise training has well-established 236 
effects on endothelial function [74], we were unable to identify the potential impact of 237 
this factor on our results. Likewise, body composition, fat distribution and blood lipids 238 
could be suggested as potential moderating factors, albeit not investigated in this meta-239 
analysis. Third, although single-dose (0.4 mg of nitroglycerin) is the common procedure 240 
to evaluate BASMF (Table 2), there are physiological and methodological variables that 241 
may affect the reproducibility of BASMF [75, 76]. In addition, the administration of 0.4 242 
mg of nitroglycerin is considered to induce a maximal NO-mediated vasodilator 243 
response [75], which could be dissociated from vascular smooth muscle submaximal 244 
responses to lower or step-wise doses of NO. In this respect, dose-response studies 245 
might have higher sensitivity to detect small differences in BASMF between older and 246 




In conclusion, the current meta-analysis provides evidence that advanced age is 249 
associated with a relatively small, but significant impairment in conduit and resistance 250 
artery SMF in healthy humans. The magnitude of vascular smooth muscle dysfunction 251 
seems more prevalent in women than in men, potentially related to the loss of 252 
circulating estrogens in women after menopause. A potential implication of our finding 253 
is that the impairment in conduit and resistance artery endothelial function with 254 
advanced age may, at least in part, be attributed to changes in vascular SMF in healthy 255 
adults. Further studies are needed to determine sex-related mechanisms that may 256 
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FIGURE 1 Flow diagram of the process of study selection 
 
FIGURE 2 Forest plot of the mean difference (MD) in brachial artery smooth muscle 
function (BASMF) between older and young groups. BASMF was expressed as the 
percentage increase in brachial artery diameter from baseline to maximal vasodilation. 
Squares represent the MD in BASMF for each study. The diamond represents the pooled 
MD in BASMF across studies. CI, confidence interval; IV, inverse variance; SD, standard 
deviation 
 
Figure 3. Forest plot of the standardized mean difference (SMD) in resistance artery 
smooth muscle function (RASMF) between older and young groups. Squares represent the 
SMD in RASMF for each study. The diamond represents the pooled SMD in RASMF across 






TABLE 1.  Main clinical characteristics of studies included in the meta-analyses 
 n Females (%) Age (years) BMI (m2/kg) 
 
SBP (mm Hg) 
 
DBP (mm Hg)  
 
Morbidities Study,  year of publication YNG OLD YNG OLD YNG OLD YNG OLD YNG OLD YNG OLD 
Studies assessing brachial artery SMF             
DeVan et al [4], 2013  21 25 12 17 24±5 62±6* 23±5 26±6* 111±11 121±12* 60±5 75±6* none 
Pierce et al [42], 2011 16 18 0 0 25±4 63±5* 26±4 27±3 118±13 124±11 69±9 78±5* none 
Black et al [3], 2009 9 8 100 100 26±3 60±6* 23±3 31±6* 101±12 122±14* 56±9 67±8* none 
Donato  et al [6], 2009 27 23 0 0 22±5 62±5* 25±5 26±5* 117±11 124±10* 63±11 78±10* none 
Walker et al [12], 2009 26 15 0 0 23±10 66±4* 24±5 26±4 116±10 124±12* 61±5 74±8* none 
Donato et al [5], 2007 51 44 0 0 23±7 63±7* 24±7 26±7* 114±7 121±13* 62±7 75±7* none 
Gates et al [39], 2007 10 12 50 50 21±3 60±7* 22±3 25±3* 105±6 114±17 60±6 70±10* none 
Parker et al [41], 2006 8 8 100 100 22±4 70±7* 22±3 25±3* 109±15 131±11* 68±7 78±11* none 
Eskurza et al [36], 2006 9 9 11 11 26±3 64±6* 24±4 26±2 110±6 108±9 60±9 71±9* none 
Eskurza et al [38], 2005 10 9 0 0 22±3 62±6* 23±3 26±3 110±9 111±12 58±6 69±3* none 
Heiss et al [40], 2005 20 20 50 65 25±4 61±9* 22±4 24±4 117±9 122±13 77±9 81±9 none 
Eskurza et al [37], 2004 11 9 0 0 25±3 64±6* 24±3 26±3 113±7 116±12 63±7 73±12* none 
McCrohon et al [10], 2000 10 10 100 100 28±5 61±3* 23±2 24±2 106±13 124±9* 75±10 79±12 none 
Woo et al A [43], 1997 19 19 68 68 29±5 63±5* 24±8 23±4 115±11 129±14* 76±10 83±8 none 
Woo et al B [43], 1997 19 19 68 68 28±6 63±4* 23±3 25±3 108±9 127±13* 75±7 79±11 none 
Mean 18 17 37 39 25 63 23 26 111 121 66 75 ― 
Studies assessing resistance artery SMF            
 23 
Millet et al [30], 2012  20 42 85 86 24±3 69±7* 22±3 23±4 116±8 128±10* 67±7 71±7* none 
Donato et al [8], 2011 16 22 25 32 25±4 64±5* 24±3 28±5* 111±12 126±14* 71±8 78±9* none 
Westby et al [24], 2011 14 14 0 0 25±4 61±7* 24±2 26±2* 114±11 125±11* 66±7 78±7* none 
Kirby et al [16], 2010 13 13 38 38 21±4 66±11* 22±2 24±3* N/A N/A N/A N/A none 
Tew et al [19], 2010 15 14 20 29 27±2 65±6* 25 27 119±12 124±12 75±9 79±7 none 
Donato et al [6], 2009 15 18 0 0 21±4 62±4* 25±4 26±4* 117±8 124±8* 63±8 78±8* none 
Nicholson et al [31], 2009 10 10 40 40 29±9 68±4* 24±3 25±2 116±16 122±13 62±8 69±12 none 
Kirby et al [17], 2009 14 14 36 36 22±4 65±7* 25±3 24±3 N/A N/A N/A N/A none 
Donato et al [32], 2008 11 14 18 29 23±7 64±4* 24±2 26±3 110±10 123±11* 71±7 78±7* none 
Galetta et al [9], 2006 16 16 50 31 27±2 65±4* 23±2 24±2 118±7 122±6 75±3 80±2* none 
Al-Shaer et al [21], 2006 15 17 47 24 22±4 62±12* 25±4 28±4* 116±12 126±12* 67±12 78±8* none 
Newcomer et al [33], 2005 8 8 0 0 24±6 67±6* 25±3 26±3 113±11 129±8* 74±11 81±8 none 
Weverling-Rijnsburger et al 
[34], 2004 7 8 0 0 22 80* N/A N/A N/A N/A N/A N/A none 
Ahlers et al [14], 2004 14 10 0 0 23±3 62±7* N/A N/A 118±11 120±19 74±11 72±13 none 
Smith et al [35], 2003 10 20 0 0 28±3 62±4* 25±5 29±3 115±9 124±9 64±9 81±9* none 
Minson et al [18], 2002 10 10 50 50 22±6 77±16* 24±3 24±3 120±13 137±19* 71±9 79±13 none 
DeSouza et al [15], 2002 22 41 0 0 28±5 61±6* 23±6 27±4* 114±14 122±13* 65±9 76±13* none 
Wang et al [20], 2002 12 10 0 0 24±3 67±3* 22±5 23±4 127±17 139±22 77±10 73±16 none 
Taddei et al [23], 2000 12 12 33 33 27±2 63±6* 23±4 24±4 119±5 119±6 77±3 78±3 none 
Gerhard et al [22], 1996 11 7 N/A N/A 20-29 60-69* N/A N/A N/A N/A N/A N/A none 
Mean 13 16 23 23 24 66 24 26 116 126 70 77 ― 
 24 
Data are n, % of females, mean or mean ± SD. One study presented two groups of older subjects, each of which had been independently compared with a young group [43], 
thus they were evaluated as individual studies (distinguished by A and B). * significantly different from young group at P<0.05 





TABLE 2. Brachial artery smooth muscle function (SMF) assessment of studies included in the meta-analysis  
Data are dose or mean ± SD. One study presented two groups of older subjects, each of which had been independently compared with a location-matched young 
group [43], thus they were evaluated as individual studies (distinguished by A and B). * significantly different from young group at P<0.05 
EF, endothelial function; N/A, data not available; NMD, nitrate-mediated dilation; NTG, nitroglycerin; OLD, older group; SMF, smooth muscle function; YNG, young 
group; ↔, no significant difference between older and young groups; ↓, significant decrease in older compared with young groups 
  
 





Study,  year of 
publication Artery 
Wall-tracking 
system YNG OLD  
 
Stimulus Dose (mg)  OLD vs. YNG 
 
OLD vs. YNG 
DeVan et al [4], 2013  brachial computerized 4.0±0.4 4.0±0.5 
 
NTG sublingual 0.4 ↔ 
 
↓ 
Pierce et al [42], 2011 brachial computerized 4.0±0.4 4.1±0.5 
 
NTG sublingual 0.4 ↔ 
 
↓ 
Black et al [3], 2009 brachial computerized 3.3±0.1 3.6±0.6 
 
NTG sublingual 0.4 ↔ 
 
↓ 
Donato  et al [6], 2009 brachial computerized N/A N/A 
 
NTG sublingual 0.4 ↔ 
 
↓ 
Walker et al [12], 2009 brachial computerized 4.1±0.4 4.4±0.5* 
 
NTG sublingual 0.4 ↔ 
 
↓ 
Donato et al [5], 2007 brachial computerized N/A N/A 
 
NTG sublingual 0.4 ↔ 
 
↓ 
Gates et al [39], 2007 brachial computerized 3.7±0.4 4.0±0.8 
 
NTG sublingual 0.4 ↔ 
 
↓ 
Parker et al [41], 2006 brachial computerized 3.0±0.5 3.1±0.4 
 
NTG sublingual 0.4 ↓ 
 
↓ 
Eskurza et al [36], 2006 brachial computerized 4.0±0.6 4.3±0.7 
 
NTG sublingual 0.4 ↔ 
 
↓ 
Eskurza et al [38], 2005 brachial computerized 4.1±0.4 4.4±0.5 
 
NTG sublingual 0.4 ↔ 
 
↓ 
Heiss et al [40], 2005 brachial computerized 3.7±0.9 4.2±0.5* 
 
NTG sublingual 0.4 ↔ 
 
↓ 
Eskurza et al [37], 2004 brachial manual 4.1±0.3 4.3±0.3 
 
NTG sublingual 0.4 ↔ 
 
↓ 
McCrohon et al [10], 2000 brachial manual 3.1±0.3 3.6±0.4* 
 
NTG sublingual 0.4 ↓ 
 
↓ 
Woo et al A [43], 1997 brachial manual 3.5±0.5 3.6±0.6 
 
NTG sublingual 0.4 ↔ 
 
↔ 
Woo et al B [43], 1997 brachial manual 3.4±0.6 3.7±0.5 
 





TABLE 3. Resistance artery smooth muscle function (SMF) assessment in studies included in the meta-analysis  
    SMF  EF 
Study,  year of 
publication 
Vascular 
region  Technique  Stimulus 
 
OLD vs. YNG  Stimulus 
 
OLD vs. YNG 
Millet et al [30], 2012  
supramedial 
malleolar (skin) laser Doppler  SNP iontophoresis ↔  local heating ↔ 
Donato et al [8], 2011 forearm plethysmography  SNP infusion ↔  ACh infusion ↓ 
Westby et al [24], 2011 forearm plethysmography  SNP infusion ↔  ACh infusion ↓ 
Kirby et al [16], 2010 forearm plethysmography  SNP infusion ↔  ACh infusion ↓ 
Tew et al [19], 2010 forearm (skin) laser Doppler  SNP iontophoresis ↓  ACh iontophoresis ↓ 
Donato et al [6], 2009 forearm plethysmography  SNP infusion ↔  ACh infusion ↓ 
Nicholson et al [31], 2009 forearm plethysmography  SNP infusion ↔  N/A N/A 
Kirby et al [17], 2009 forearm plethysmography  SNP infusion ↓  ACh infusion ↓ 
Donato et al [32], 2008 forearm plethysmography  SNP infusion ↔  ACh infusion ↓ 
Galetta et al [9], 2006 forearm plethysmography  SNP infusion ↔  ACh infusion ↓ 
Al-Shaer et al [21], 2006 forearm plethysmography  SNP infusion ↓  ACh infusion ↓ 
Newcomer et al [33], 2005 lega  ultrasound  SNP infusion ↔  ACh infusion ↓ 
Weverling-Rijnsburger et al 
[34], 2004 forearm plethysmography  SNP infusion ↔  ACh infusion ↔ 
Ahlers et al [14], 2004 forearm plethysmography  SNP infusion ↔  ACh infusion ↓ 
Smith et al [35], 2003 forearm plethysmography  SNP infusion ↔  Bk infusion ↔ 
Minson et al [18], 2002 forearm (skin) laser Doppler  SNP microdialysis ↓  local heating ↓ 








a Leg and forearm resistance artery SMF were reported. Leg resistance artery SMF was used in meta-analysis because of lower (as compared with forearm) 
coefficient of variation  
ACh, acetylcholine; Bk, bradykinin; EF, endothelial function; N/A, data not available; OLD, older group; SMF, smooth muscle function; SNP, sodium 

















Wang et al [20], 2002 lower leg (skin) laser Doppler  SNP iontophoresis ↔  ACh iontophoresis ↓ 
Taddei et al [23], 2000 forearm plethysmography  SNP infusion ↓  ACh infusion ↓ 
Gerhard et al [22], 1996 forearm plethysmography  SNP infusion ↔  ACh infusion ↓ 
